Title of Invention

"2-(PYRIDIN-2-YL)-PYRIMIDINES AND THEIR USE FOR CONTROLLING HARMFUL FUNGI"

Abstract The invention relates to 2-(pyridin-2-yl)-pyrimidine compounds of general formula (I) and their use for controlling pathogenic fungi and as plant protection products that, as an active constituent, contain compounds of this type, whereby: k represents 0, 1, 2, 3; m represents 0, 1, 2, 3, 4 or 5; n represents 1, 2, 3, 4 or 5; R1 , independent of one another, represents halogen, OH, CN, NO2, C1-C4 alkyl, C1-C4 alkyl halide, C1-C4 alkoxy, C1-C4 alkoxy halide, C2-C4 alkenyl, C2-C4 alkynyl, C3-C8 cycloalkyl, C1-C4 alkoxy-C1-C4 alkyl, amino, phenoxy, which is optionally substituted by halogen or C1-C4 alkyl, NHR, NR2, C(Ra)=N-ORb, S(=O)pAl or C(=O)A2, or two radicals R1 bound to adjacent carbon atoms can, together, also represent a group -O-Alk-O-, wherein Alk represents a linear or branched C1-C4 alkylene, and 1, 2, 3 or 4 hydrogen atoms can also be replaced by halogen; R2 represents C1-C4 alkyl halide, C1-C4 alkoxy, C1-C4 alkoxy halide, hydroxy, halogen, CN or NO2; whereby R2 can also represent hydrogen or C1-C4 alkyl when at least one of the three following conditions is fulfilled: n represents 3, 4 or 5; k represents 1, 2 or 3; if m is not equal to 0, at least one of the radicals R1 represents a radical that differs from halogen, C1-C4 alkyl, C1-C4 alkoxy and C1-C4 alkyl halide, and; R3 represents C1-C4 alkyl.
Full Text 2-(Pyridin-2-yl)-pyrimidines and their use for controlling harmful fungi
Description
The present invention relates to 2-(pyridin-2-yl)pyrimidines and to their use for
controlling harmful fungi, and also to crop protection compositions comprising such
compounds as an effective component.
EP-A 234 104 describes 2-(pyridin-2-yl)pyrimidines which have an alkyl group in the
6-position of the pyridine radical and which may have a fused saturated 5- or
6-membered ring in the 3,4-position of the pyrimidine ring. The compounds are
suitable for controlling phytopathogenicfungi (harmful fungi).
US 4,873,248 discloses 2-(pyridin-2-yl)pyrimidines having fungicidal action which carry
an optionally substituted phenyl ring in the 4-position of the pyrimidine ring.
EP-A 259 139 describes 2-(pyridin-2-yl)pyrimidines of the formula A

in which a is 0, 1, 2, 3, 4 or 5, Ra is halogen, lower alkyl, lower alkoxy or haloalkyl, Rb
and Rc independently of one another are hydrogen or C1-C4-alkyl, Rd is hydrogen or
lower alkyl, Re is hydrogen, lower alkyl or halogen or together with Rd is propane-1,3-
diyl or butane-1,4-diyl and Rf is inter alia hydrogen, alkyl, lower alkoxy or lower
alkylthio.
With respect to their fungicidal action, some of the 2-(pyridin-2-yl)pyrimidines known
from the prior art are unsatisfactory, or they have unwanted properties, such as poor
compatibility with useful plants.
Accordingly, it is an object of the present invention to provide novel compounds having
improved fungicidal activity and/or better compatibility with useful plants.

Surprisingly, this object is achieved by 2-(pyridin-2-yl)pyrimidine compounds of the
formula I

in which:
k is 0, 1, 2 or 3;
m is 0, 1,2, 3, 4 or 5;
n is 1, 2, 3, 4 or 5;
R1 independently of one another are halogen, OH, CN, NO2, C1-C4-alkyl, C1-C4-
haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C3-C8-
cycloalkyl, C1-C4-alkoxy-C1-C4-alkyl, amino, phenoxy which is optionally
substituted by halogen or C1-C4-alkyl, NHR, NR2, C(Ra)=N-ORb, S(=O)pA1 or C
(=O)A2, where p, R, Ra, Rb, A1 and A2 are as defined below:
R is C1-C4-alkyl or C1-C4-alkylcarbonyl,
Ra is hydrogen or C1-C4-alkyl,
Rb is C1-C4-alkyl, C3-C4-alkenyl or C3-C4-alkynyl,
p is 0, 1 or 2,
A1 is C1-C4-alkyl or for p = 2 also NH2, C1-C4-alkylamino or di-(C1-C4-alkyl)
amino, and
A2 is hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkylamino, di-(C1-C4-alkyl)amino,
C2-C4-alkenyl, C1-C4-alkoxy or C1-C4-haloalkoxy;
or two radicals R1 attached to adjacent carbon atoms together may also be a
group -O-Alk-O- where Alk is straight-chain or branched C1-C4-alkylene and
where 1, 2, 3 or 4 hydrogen atoms may also be replaced by halogen;

R2 is C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, hydroxyl, halogen, CN or NO2;
where R2 may also be hydrogen or C1-C4-alkyl if at least one of the following
three conditions is met:
n is 3, 4 or 5,
k is 1,2 or 3,
for m at least one of the radicals R1 is a radical different from halogen,
C1-C4-alkyl, C1-C4-alkoxy and C1-C4-haloalkyl; and
R3 is C1-C4-alkyl;
and by the agriculturally acceptable salts of the compounds I.
The present invention therefore provides 2-(pyridin-2-yl)pyrimidines of the formula I
and their agriculturally acceptable salts.
The present invention furthermore provides the use of the 2-(pyridin-2-yl)pyrimidines of
the formula I and their agriculturally acceptable salts for controlling phytopathogenic
fungi (= harmful fungi), and also a method for controlling phytopathogenic fungi which
comprises treating the fungi or the materials, plants, the soil or seed to be protected
against fungal attack with an effective amount of a compound of the formula I and/or
with an agriculturally acceptable salt of I.
The present invention furthermore provides a composition for controlling harmful fungi,
which compositions comprise at least one 2-(pyridin-2-yl)pyrimidine compound of the
formula I and/or an agriculturally acceptable salt thereof and at least one liquid or solid
carrier.
Depending on the substitution pattern, the compounds of the formula I and their
tautomers may have one or more centers of chirality, in which case they are present as
pure enantiomers or pure diastereomers or as enantiomer or diastereomer mixtures.
The invention provides both the pure enantiomers or diastereomers and also their
mixtures.
Suitable agriculturally useful salts are especially the salts of those cations or the acid
addition salts of those acids whose cations and anions, respectively, have no adverse
effect on the fungicidal action of the compounds I. Suitable cations are thus in
particular the ions of the alkali metals, preferably sodium and potassium, of the
alkaline earth metals, preferably calcium, magnesium and barium, and of the transition
metals, preferably manganese, copper, zinc and iron, and also the ammonium ion
which, if desired, may carry one to four C1-C4-alkyl substituents and/or one phenyl or
benzyl substituent, preferably diisopropylammonium, tetramethylammonium,
tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions,

sulfonium ions, preferably tri(C1-C4-alkyl)sulfonium, and sulfoxonium ions, preferably tri
(C1-C4-alkyl)sulfoxonium.
Anions of useful acid addition salts are primarily chloride, bromide, fluoride,
hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate,
nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate,
and also the anions of C1-C4-alkanoic acids, preferably formate, acetate, propionate
and butyrate. They can be formed by reacting I with an acid of the corresponding
anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid
or nitric acid.
In the definitions of the variables given in the formulae above, collective terms are
used which are generally representative of the substituents in question. The term Cn-
Cm denotes the number of carbon atoms in the substituent or substituent moiety
possible in each case:
halogen: fluorine, chlorine, bromine and iodine;
alkyl and all alkyl moieties in alkoxy, aikoxyalkyl, alkylamino and dialkylamino:
saturated straight-chain or branched hydrocarbon radicals having 1 to 4 carbon atoms,
for example C1-C4-alkyl, such as methyl, ethyl, propyl, 1-methylethyl, butyl,
1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl;
haloalkyl: straight-chain or branched alkyl groups having 1 to 4 carbon atoms (as
mentioned above), where some or all of the hydrogen atoms in these groups may be
replaced by halogen atoms as mentioned above and in particular by fluorine or
chlorine, in particular C1-C2-haloalkyl, such as chloromethyl, bromomethyl,
dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl,
chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-
bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-
2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl,
pentafluoroethyl and 1,1,1 -trifluoroprop-2-yl;
alkenyl: monounsaturated straight-chain or branched hydrocarbon radicals having 2 to
4 or 3 to 4 carbon atoms and one double bond in any position, for example ethenyl, 1-
propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-
propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl;
alkynyl: straight-chain or branched hydrocarbon groups having 2 to 4 or 3 to 4 carbon
atoms and a triple bond in any position, for example ethynyl, 1-propynyl, 2-propynyl, 1-

butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl;
cycloalkyl: monocyclic saturated hydrocarbon groups having 3 to 8, preferably up to
6, carbon ring members, such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl;
alkylamino: an alkyl group attached via an NH group, in which alkyl is one of the
above-mentioned alkyl radicals having 1 to 4 carbon atoms, such as methylamino,
ethylamino, n-propylamino, isopropylamino, n-butylamino and the like;
dialkylamino: a radical of the formula N(alkyl)2 in which alkyl is one of the above-
mentioned alkyl radicals having 1 to 4 carbon atoms, for example dimethylamino,
diethylamino, methylethylamino, N-methyl-N-propylamino and the like;
C1-C4-alkoxy: an alkyl group which is attached via oxygen and has 1 to 4 carbon
atoms, for example methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1-
methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy;
C1-C4haloalkoxy: a C1-C4-alkoxy radical as mentioned above which is partially or fully
substituted by fluorine, chlorine, bromine and/or iodine, preferably by fluorine, i.e., for
example, OCH2F, OCHF2, OCF3, OCH2CI, OCHCI2, OCCI3, chlorofluoromethoxy,
dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-
bromoethoxy, 2-iodoethoxy, 2,2-difIuoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-
fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-
trichloroethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-
difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-
bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-
C2F5, OCF2-C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2CI)-2-chloroethoxy, 1-(CH2Br)-2-
bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy,
alkylene: a straight-chain saturated hydrocarbon chain having 2 to 6 and in particular
2 to 4 carbon atoms, such as ethane-1,2-diyl, propane-1,3-diyl, butane-1,4-diyl,
pentane-1,5-diyl or hexane-1,6-diyl.
A first embodiment of the invention relates to compounds in which n is 3, 4 or 5 and in
particulars or4, R2 is hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-
haloalkoxy, hydroxyl, halogen, CN or NO2 and the other variables have the meanings
mentioned above, in particular the meanings mentioned below as being preferred.
A second embodiment of the invention relates to compounds in which n is 1 or 2 and in
particular 2, R2 is C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, hydroxyl, halogen,
CN or NO2 and the other variables have the meanings mentioned above, in particular
the meanings mentioned below as being preferred.

With a view to the use as fungicides, preference is given to those compounds of the
formula I in which the variables m, n, k, R1, R2 and R3 independently of one another
and in particular in combination have the meanings below.
m is 0 or an integer 1, 2 or 3;
n is 1, 2 or 3, especially 2 or 3;
k is 0, 1 or 2, especially 0. If k is different from 0, the radical(s) R3 can be located
in any position of the saturated fused ring. In a particularly preferred
embodiment, k is 0. In a further preferred embodiment, k is 2. In this
embodiment, the two radicals R3 are preferably located at the same carbon atom.
R1 is halogen, in particular fluorine, chlorine or bromine, cyano, OH, CHO, NO2,
NH2, methylamino, dimethylamino, diethylamino, C1-C4-alkyl, in particular methyl,
isopropyl ortert-butyl, C3-C8-cycloalkyl, especially cyclopropyl, cyclopentyl or
cyclohexyl, C1-C4-alkoxy, especially OCH3, C1-C4-alkylthio, especially methylthio
or ethylthio, C1-C4-haloalkyl, in particular C1-C2-fluoroalkyl, especially CF3, C1-C4-
haloalkoxy, especially OCHF2 or OCF3, or CO(A2) where A2 is C1-C4-alkoxy,
especially OCH3, or a C1-C4-alkyl, especially methyl. Preference is also given to
compounds in which one of the radicals R1 is a group C(Ra)=NORb in which Ra
and Rb are as defined above and in which Ra is in particular H or CH3 and Rb is in
particular C1-C4-alkyl, propargyl or allyl.
Particularly preferably R1 is selected from among halogen, in particular F or CI,
CN, C1-C4-alkyl, in particular methyl, isopropyl ortert-butyl, d-C4-haloalkyl, in
particular C1-C2-fluoroalkyl, especially trifluoromethyl, C1-C4-alkoxy, in particular
methoxy, ethoxy, isopropyloxy, C1-C4-alkylthio, e.g. methylthio, or C1-C4-
haloalkoxy, in particular OCF3 or OCHF2 or one of the radicals is a group C(Ra)
=NO-Rb or a group C(0)-A2.
Very particularly preferred radicals R1 are selected from the group consisting
of methyl, F, CI, methoxy, trifluoromethyl and CN. Likewise particularly preferred
radicals are selected from the group consisting of CH(=NOCH3), C(CH3)
(=N-OCH3), C(CH3)(=N-OC2H5), C(O)CH3 and CO2CH3.
R2 is C1-C4-haloalkyl, preferably C1-C2-fluoroalkyl and especially trifluoromethyl, C1-
C4-alkoxy, C1-C4-haloalkoxy, halogen, CN or NO2, in particular C1-C4-alkoxy,
especially methoxy or ethoxy, C1-C4-haloalkoxy, in particular trifluoromethoxy or
difluoromethoxy, or halogen, especially F, CI or Br.

Preference is also given to compounds of the formula I where n = 3, 4 or 5 in which R2
is hydrogen or in particular C1-C4-alkyl and particularly preferred methyl or ethyl.
Preference is likewise given to compounds of the formula I where k = 1, 2 or 3 and
especially 2, in which R2is hydrogen or in particular C1-C4-alkyl and particularly
preferably methyl or ethyl.
R3 is methyl or isopropyl.
Among the compounds of the formula I, particular preference is given to those in which
the phenyl group substituted by (R1)m is the group of the formula P

in which # is the point of attachment to the pyridine ring and R11, R12, R13, R14 and R15
have the meanings given for R1, in particular the meanings given as being preferred or
particularly preferred. In a preferred embodiment, at least one and especially 1, 2, or 3
of the radicals R11, R12, R13, R14 and R15 is different from hydrogen. In another preferred
embodiment, all of the radicals R11, R12, R13, R14 and R15 are hydrogen. In particular:
R11 is hydrogen, fluorine, chlorine, CH3, OCH3, OCHF2, OCF3 or CF3;
R12, R14 independently of one another are hydrogen, chlorine, fluorine, CH3, OCH3,
OCHF2, OCF3 or CF3, where one of the radicals R12 and R14 may also be
NO2, C(0)CH3 or COOCH3; in particular R12 and R14 are hydrogen, fluorine,
methyl or trifluoromethyl;
R13 is hydrogen, fluorine, chlorine, cyano, OH, CHO, NO2, NH2, methylamino,
dimethylamino, diethylamino, C1-C4-alkyl, especially CH3, C2H5, CH(CH3)2,
C3-C8-cycloalkyl, especially cyclopropyl, cyclopentyl or cyclohexyl, C1-C4-
alkoxy, especially OCH3, C1-C4-alkylthio, especially methylthio or ethylthio,
C1-C4-haloalkyl, especially CF3, C1-C4-haloalkoxy, especially OCHF2 or
OCF3, or CO(A2) in which A2 is C1-C4-alkyl, especially methyl or C1-C4-
alkoxy, especially OCH3, or R12 and R13 together form a group O-CH2-O;
and
R15 is hydrogen, fluorine, chlorine or C1-C4-alkyl, especially CH3,in particular hydrogen
or fluorine.

Preference is also given to compounds in which R12 or R13 is a group C(Ra)=NORb in
which Ra and Rb have the meanings given above, in particular the meanings mentioned
as being preferred.
If more than one of the radicals R11, R12, R13, R14 or R15 is different from hydrogen,
advantageously only one of the radicals different from hydrogen is different from
halogen or methyl. Especially if one of the radicals R11, R12, R13, R14 or R15 is different
from hydrogen, halogen or methyl, the remaining radicals R11, R12, R13, R14, R15are
selected from the group consisting of halogen and hydrogen.
Examples of radicals P are in particular those in which R11, R12, R13, R14 and R15
together have the meanings given in one row of table A:







A particularly preferred embodiment of the invention is the compounds of the formula
la

in which R11, R12, R13, R14 and R15 have the meanings mentioned above and in
particular the meanings mentioned as being preferred and R2 has the meanings
mentioned above which are different from H and C1-C4-alkyl and is in particular C1-C4-
alkoxy, especially methoxy, ethoxy, isopropyloxy, tert-butyloxy, C1-C2-fluoroalkyloxy,
especially difluoromethoxy or trifluoromethoxy, CN, NO2 or OH. Examples of these
compounds are the compounds of the formula la given in tables 1 to 9 below in which
R11, R12, R13, R14 and R15 together have the meanings given in one of rows 2 to 144 of
table A.
Table 1:
Compounds of the formula la in which R2 is methoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 2:
Compounds of the formula la in which R2 is ethoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 3:
Compounds of the formula la in which R2 is isopropyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 4:
Compounds of the formula la in which R2 is tert-butyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 5:

Compounds of the formula la in which R2 is trifluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 2 to 144 of table A.
Table 6:
Compounds of the formula la in which R2 is difluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 2 to 144 of table A.
Table 7:
Compounds of the formula la in which R2 is CN and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 2 to 144 of table A.
Table 8:
Compounds of the formula la in which R2 is nitro and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 2 to 144 of table A.
Table 9:
Compounds of the formula la in which R2 is OH and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 2 to 144 of table A.
A further particularly preferred embodiment of the invention is the compounds of the
formula lb

in which R11, R12, R13, R14 and R15 have the meanings mentioned above and in
particular the meanings mentioned as being preferred and R2 has the meanings
mentioned above and is in particular C1-C4-alkyl, especially methyl, ethyl, n-propyl,
isopropyl, n-butyl, 2-butyl or tert-butyl, C1-C4-alkoxy, especially methoxy, ethoxy,
isopropyloxy or tert-butyloxy, C1-C2-fluoroalkyl, especially trifluoromethyl or
pentafluoroethyl, C1-C2-fluoroalkyloxy, especially difluoromethoxy or trifluoromethoxy,
halogen, especially fluorine, chlorine or bromine, CN, NO2 or OH. Examples of these
compounds are the compounds of the formula lb given in tables 10 to 30 below in
which R11, R12, R13, R14 and R15 together have the meanings given in one of rows 1 to
144 of table A.
Table 10:

Compounds of the formula lb in which R2 is methyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 11:
Compounds of the formula lb in which R2 is ethyl and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 12:
Compounds of the formula lb in which R2 is n-propyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 13:
Compounds of the formula lb in which R2 is isopropyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 14:
Compounds of the formula lb in which R2 is n-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 15:
Compounds of the formula lb in which R2 is 2-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 16:
Compounds of the formula lb in which R2 is tert-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 17:
Compounds of the formula lb in which R2 is methoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 18:
Compounds of the formula lb in which R2 is ethoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 19:
Compounds of the formula lb in which R2 is isopropyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 20:
Compounds of the formula lb in which R2 is tert-butyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.

Table 21:
Compounds of the formula lb in which R2 is trifluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 22:
Compounds of the formula lb in which R2 is difluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 23:
Compounds of the formula lb in which R2 is trifluoromethyl and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 24:
Compounds of the formula lb in which R2 is pentafluoroethyl and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 25:
Compounds of the formula lb in which R2 is fluorine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 26:
Compounds of the formula lb in which R2 is chlorine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 27:
Compounds of the formula lb in which R2 is bromine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 28:
Compounds of the formula lb in which R2 is CN and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 29:
Compounds of the formula lb in which R2 is NO2 and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 30:
Compounds of the formula lb in which R2 is OH and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.

A'further particularly preferred embodiment of the invention is the compounds of the
formula Ic

in which R11, R12, R13, R14 and R15 have the meanings mentioned above and in
particular the meanings mentioned as being preferred and R2 has the meanings
mentioned above which are different from H and C1-C4-alkyl and is in particular C1-C4-
alkoxy, especially methoxy, ethoxy, isopropyloxy, tert-butyloxy, C1-C2-fluoroalkyloxy,
especially difluoromethoxy or trifluoromethoxy, CN, NO2 or OH. Examples of these
compounds are the compounds of the formula Ic given in tables 31 to 39 below in
which R11, R12, R13, R14 and R15 together have the meanings given in one of rows 2 to
144 of table A.
Table 31:
Compounds of the formula Ic in which R2 is methoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 32:
Compounds of the formula Ic in which R2 is ethoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 33:
Compounds of the formula Ic in which R2 is isopropyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 34:
Compounds of the formula Ic in which R2 is tert-butyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 2 to 144 of table A.
Table 35:
Compounds of the formula Ic in which R2 is trifluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 2 to 144 of table A.
Table 36:

Compounds of the formula Ic in which R2 is difluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 2 to 144 of table A.
Table 37:
Compounds of the formula Ic in which R2 is CN and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 2 to 144 of table A.
Table 38:
Compounds of the formula Ic in which R2 is nitro and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 2 to 144 of table A.
Table 39:
Compounds of the formula Ic in which R2 is OH and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 2 to 144 of table A.
A further particularly preferred embodiment of the invention is the compounds of the
formula Id

in which R11, R12, R13, R14 and R15 have the meanings mentioned above and in
particular the meanings mentioned as being preferred and R2 has the meanings
mentioned above and is in particular C1-C4-alkyl, especially methyl, ethyl, n-propyl,
isopropyl, n-butyl, 2-butyl or tert-butyl, C1-C4-alkoxy, especially methoxy, ethoxy,
isopropyloxy or tert-butyloxy, C1-C2-fluoroalkyl, especially trifluoromethyl or
pentafluoroethyl, C1-C2-fluoroalkyloxy, especially difluoromethoxy or trifluoromethoxy,
halogen, especially fluorine, chlorine or bromine, CN, NO2 or OH. Examples of these
compounds are the compounds of the formula Id given in tables 40 to 60 below in
which R11, R12, R13, R14 and R15 together have the meanings given in one of rows 1 to
144 of table A.
Table 40:
Compounds of the formula Id in which R2 is methyl and R11, R12, R13, R14 and R16
together have the meanings given in one of rows 1 to 144 of table A.
Table 41:

Compounds of the formula Id in which R2 is ethyl and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 42:
Compounds of the formula Id in which R2 is n-propyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 43:
Compounds of the formula Id in which R2 is isopropyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 44:
Compounds of the formula Id in which R2 is n-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 45:
Compounds of the formula Id in which R2 is 2-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 46:
Compounds of the formula Id in which R2 is tert-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 47:
Compounds of the formula Id in which R2 is methoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 48:
Compounds of the formula Id in which R2 is ethoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 49:
Compounds of the formula Id in which R2 is isopropyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 50:
Compounds of the formula Id in which R2 is tert-butyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 51:

Compounds of the formula Id in which R2 is trifluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 52:
Compounds of the formula Id in which R2 is difluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 53:
Compounds of the formula Id in which R2 is trifluoromethyl and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 54:
Compounds of the formula Id in which R2 is pentafluoroethyl and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 55:
Compounds of the formula Id in which R2 is fluorine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 56:
Compounds of the formula Id in which R2 is chlorine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 57:
Compounds of the formula Id in which R2 is bromine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 58: .
Compounds of the formula Id in which R2 is CN and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 59:
Compounds of the formula Id in which R2 is NO2 and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 60:
Compounds of the formula Id in which R2 is OH and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
A further preferred embodiment of the invention is the compounds of the formula le,


in which R11, R12, R13, R14 and R15 have the meanings mentioned above and in
particular the meanings mentioned as being preferred and R2 has the meanings
mentioned above and is in particular C1-C4-alkyl, especially methyl, ethyl, n-propyl,
isopropyl, n-butyl, 2-butyl or tert-butyl, C1-C4-alkoxy, especially methoxy, ethoxy,
isopropyloxy or tert-butyloxy, C1-C2-fluoroalkyl, especially trifluoromethyl or
pentafluoroethyl, C1-C2-fluoroalkyloxy, especially difluoromethoxy or trifluoromethoxy,
halogen, especially fluorine, chlorine or bromine, CN, NO2 or OH. Examples of these
compounds are the compounds of the formula le given in tables 61 to 81 below in
which R11, R12, R13, R14 and R15 together have the meanings given in one of rows 1 to
144 of table A.
Table 61:
Compounds of the formula le in which R2 is methyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 62:
Compounds of the formula le in which R2 is ethyl and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 63:
Compounds of the formula le in which R2 is n-propyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 64:
Compounds of the formula le in which R2 is isopropyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 65:
Compounds of the formula le in which R2 is n-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 66:

Compounds of the formula le in which R2 is 2-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 67:
Compounds of the formula le in which R2 is tert-butyl and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 68:
Compounds of the formula le in which R2 is methoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 69:
Compounds of the formula le in which R2 is ethoxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 70:
Compounds of the formula le in which R2 is isopropyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 71:
Compounds of the formula le in which R2 is tert-butyloxy and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 72:
Compounds of the formula le in which R2 is trifluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 73:
Compounds of the formula le in which R2 is difluoromethoxy and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.

Table 74:
Compounds of the formula le in which R2 is trifluoromethyl and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 75:
Compounds of the formula le in which R2 is pentafluoroethyl and R11, R12, R13, R14 and
R15 together have the meanings given in one of rows 1 to 144 of table A.
Table 76:
Compounds of the formula le in which R2 is fluorine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 77:
Compounds of the formula le in which R2 is chlorine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 78:
Compounds of the formula le in which R2 is bromine and R11, R12, R13, R14 and R15
together have the meanings given in one of rows 1 to 144 of table A.
Table 79:
Compounds of the formula le in which R2 is CN and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 80:
Compounds of the formula le in which R2 is NO2 and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
Table 81:
Compounds of the formula le in which R2 is OH and R11, R12, R13, R14 and R15 together
have the meanings given in one of rows 1 to 144 of table A.
The compounds of the formula I according to the invention can be prepared, for
example, according to the process shown in scheme 1:


In scheme 1, R1, R3, m, n and k are as defined above. R2a is H, C1-C4-alkyl, C1-C4-
haloalkyl, halogen, C1-C4-alkoxy, C1-C4-haloalkoxy, NO2 or OH. R is H or C1-C4-alkyl or,
together with further molecules lla, forms a phenylboronic acid anhydride. R' is C1-C4-
alkyl and in particular methyl.
In a first step i), a 2-bromopyridine is reacted with a phenylboronic acid derivative of
the formula lla under the conditions of a Suzuki coupling, i.e. in the presence of a
platinum metal catalyst and in particular in the presence of a palladium catalyst, under
reaction conditions known per se, as known, for example, from Ace. Chem. Res. 15
(1982), 178-184, Chem. Rev. 95 (1995), 2457-2483 and the literature cited therein,
and also from J. Org. Chem. 68 (2003), 9412. Suitable catalysts are in particular
tetrakis(triphenylphosphine)palladium(0), bis(triphenylphosphine)palladium(ll) chloride,
bis(acetonitrile)palladium(ll) chloride, [1,1'-bis(diphenylphosphine)ferrocene]palladium
(II) chloride/dichloromethane complex, bis[1,2-bis(diphenylphosphine)ethane]palladium

(0) and [1,4-bis(diphenylphosphine)butane]palladium(ll) chloride. The amount of
catalyst is usually from 0.1 to 10 mol%.
The resulting 2-phenylpyridine of the formula III is subsequently, in step ii), converted
by treatment with a peracid under conditions known per se into the 2-phenylpyridine N-
oxide of the formula IV. The conversion of III into IV can be carried out analogously to
known processes, for example by treating III with hydrogen peroxide in an organic
acid, such as formic acid, acetic acid, chloroacetic acid or trifluoroacetic acid (see, for
example, J. Org. Chem. 55 (1990), 738-741 and Organic Synthesis, Collect. Vol. IV
(1963), 655-656), or by reacting III with an organic peracid, such as meta-
perchlorobenzoic acid, in an inert solvent, for example a halogenated hydrocarbon,
such as dichloromethane or dichloroethane (see, for example, Synthetic Commun. 22
(18) (1992), 2645; J. Med. Chem. (1998), 2146). The conversion of III into IV can also
be achieved analogously to the method described by K.B. Scharpless (J. Org. Chem.
63 (5) (1998), 7740) by reacting III with hydrogen peroxide in a halogenated
hydrocarbon, such as dichloromethane or dichloroethane, in the presence of catalytic
amounts (for example 5% by weight) of rhenium(VII) compounds, such as
methyltrioxorhenium (H3CReO3).
The conversion of the 2-phenylpyridine N-oxide of the formula IV into the nitrile V in
step iii) can be carried out, for example, by a modified Reissert-Henze reaction
analogously to the methods described in J. Org. Chem. 48 (1983), 1375 and J. Org.
Chem. 55 (1990), 738-741, by reacting IV with a trialkylsilyl cyanide, such as
trimethylsilyl cyanide, in the presence of N,N-dimethyichloroformamide. Alternatively,
the nitrile V can be prepared from the 2-phenylpyridine N-oxide IV by successive
reaction with dimethyl sulfate and then with cyanide ions, for example with sodium
cyanide or potassium cyanide, analogously to the method described in Tetrahedron
(1985), 4947.
The 2-cyano-6-phenylpyridine compound, obtained in step iii), of the formula V is then,
in step iv), converted by the method described in US 4,873,248 into the amidinium
hydrochloride of the formula VI. The conversion is carried out by successive treatment
with alkali metal alkoxide, such as sodium methoxide or sodium ethoxide, and
subsequent reaction with ammonium chloride. Instead of the hydrochlorides, it is also
possible to use the hydrobromides, acetates, sulfates or formates in the subsequent
step v).
The resulting amidinium hydrochloride of the formula VI is then, in step v), reacted with
a dialkylaminomethylenecycloalkanone of the formula VII (enamino ketone VII) in the
presence of a base, preferably an alkali metal alkoxide, such as sodium methoxide or
sodium ethoxide. The reaction can be carried out analogously to known processes for

reacting amidinium hydrochlorides with enamino ketones, as described, for example, in
J. Heterocycl. Chem. 20 (1983), 649-653.
Instead of the enamino ketones VII, it is also possible to use, in step v), B-oxoacetals
of the formula Vila

In formula VIla, R" is C1-C4-alkyl and in particular methyl or ethyl. The reaction of VI
with VIla can be carried out analogously to the method (a) described in EP-A 259139,
which is incorporated herein by way of reference.
Dialkylaminomethylenecycloalkanones of the formula VII are known or can be
prepared analogously to known methods (see, for example, WO 2001/087845,
Tetrahedron 50(7) (1994), 2255-2264; Synthetic Communications 28(10) (1998), 1743-
1753 or Tetrahedron Letters 27(23) (1986), 2567-70). ß-Oxoacetals of the formula VIla
are likewise known, for example from EP 259139, or can be obtained commercially.
Alternatively, the compounds of the formula I can be prepared by the synthesis route
shown in Scheme 2:
Scheme 2:


In Scheme 2, R, R', R1, R3, m, n and k are as defined above. R2a is H, C1-C4-alkyl or C1-
C4-haloalkyl. Hal is bromine or chlorine.
With respect to the reaction conditions for step vi), what was said for step iv) in
Scheme 1 applies. With respect to the reaction conditions for step vii), what was said
for step v) in Scheme 1 applies. With respect to the reaction conditions for step viii),
what was said for step i) in Scheme 1 applies. Cyanopyridines of the formula VII are
known, for example from US 2003/087940, WO 2004/026305, WO 01/057046 and
Bioorg. Med. Chem. Lett. (2003), 1571-1574, or they can be prepared by known
preparation processes.
Compounds of the formula VII can be prepared, in particular, by the process shown in
scheme 3.
Scheme 3:

In Scheme 3, R, R1 and m are as defined above. R2a is C1-C4-alkyl, C1-C4-haloalkyl,
halogen, C1-C4-alkoxy, C1-C4-haloalkoxy or NO2. Hal and Hal* independently of one
another are chlorine or bromine, where Hal* may also be iodine.
The conversion of the 2-halopyridine X into the 2-cyanopyridine XI in step ix) is
achieved by standard methods of organic chemistry by reacting X with cyanide ions,
for example with sodium cyanide or potassium cyanide (see EP-A 97460, preparation
example 1), copper(l) cyanide (see EP-A 34917, preparation example 3) or
tetramethylsilyl cyanide. The resulting compound XI is subsequently, analogously to
the methods illustrated in Scheme 1, step ii), converted into the pyridine N-oxide XII
(step x). XII is subsequently, in step xi), reacted with a halogenating agent, such as

POCI3 or POBr3, which gives the corresponding compound VII. For reacting XII in step
ix), the halogenating agent is generally employed in excess, based on the
stoichiometry of the reaction. The reaction can be carried out in an inert organic
solvent and is frequently carried out in the absence of a solvent, in which case the
halogenating agent then generally acts as solvent. The reaction temperature is usually
in the range from 20°C to the boiling point of the halogenating agent. The compound
VII can subsequently, by the method shown in Scheme 2, be converted into the
compound I. Alternatively, the compound VII can initially be reacted with phenylboronic
acid, by the methods mentioned in Scheme 1, step i) or Scheme 2, step viii), which
gives the compounds of the formula V which are then, according to steps iv) and v) of
Scheme 1, converted into the compound of the formula I according to the invention.
Instead of the boronic acid (derivatives) lla, it is also possible to use phenyl-Grignard
compounds of the formula lib in Scheme 1, step i), Scheme 2, step viii) and Scheme 3,
step xii).

In formula lIb, R1 and m are as defined above. Hal* is chlorine, bromine or iodine. The
coupling reaction in Scheme 1, step i), Scheme 2, step viii) and Scheme 3, step xii) is
then carried out in the presence of the palladium catalysts mentioned above or in the
presence of tris(acetylacetonato)iron(lll) (see Tetrahedron Lett. (2002), 3547), under, if
appropriate, slightly modified conditions, where the catalyst is usually employed in an
amount of from 0.2 to 8 mol%, in particular 0.5 to 5 mol%, based on the Grignard
compound lib to be coupled. The particularly preferred catalyst is [1,4-bis(diphenyl-
phosphine)butane]palladium(ll) chloride. The reactions are generally carried out at
temperatures in the range from -40 to +120°C and in particular in the range from 20 to
100°C. The reactions are usually carried out in an inert aprotic organic solvent,
preferably an ether and in particular a cyclic ether, such as tetrahydrofuran, or in a
mixture of different aprotic inert solvents, where preferably one of the solvents is a
cyclic ether, such as tetrahydrofuran. Examples of such mixtures are tetrahydrofuran/
N-methylpyrrolidone, tetrahydrofuran/toluene or xylene, tetrahydrofuran/dioxane,
tetrahydrofuran/N,N-dimethylpropyleneurea (DMPU) and also
tetrahydrofuran/sulfolane.
A further route to the compounds of the formula I where R2 = H, alkyl, alkoxy or in
particular CN is illustrated in Scheme 4.
Scheme 4:


In Scheme 4, n, R3 and k are as defined above. R2b is H, C1-C4-alkyl or C1-C4-alkoxy
and in particular CN. Hal* is chlorine, bromine or, in particular, iodine. The preparation
of the Grignard compound XIV from the 2-halopyridine XIII can be carried out by
processes known per se, as described, for example, in Synlett (1998), 1359.
The subsequent coupling of XIV with the 2-chloropyrimidine compound XV in step xiv)
is carried out analogously to the coupling of Grignard compounds Mb already
illustrated. The coupling is preferably carried out in the presence of a transition metal
catalyst of a metal of group 8 to 10 (according to IUPAC 1989), in particular a
palladium, nickel or iron catalyst. With respect to the catalyst, reference is made to the
catalysts mentioned above. The reaction is carried out in a solvent customary for this
purpose, for example an ether, such as diethyl ether, dioxane, tetrahydrofuran, an
aromatic hydrocarbon, such as toluene or xylenes, or an aprotic amide, lactam or urea,
such as N-methylpyrrolidone or dimethylpropyleneurea, or in mixtures of these
solvents, in particular mixtures comprising at least one ether. The reaction
temperatures are generally in the range from -40 to +120°C and in particular in the
range from 20 to 100°C. For further details, reference is made to the methods
described in J. Am. Chem. Soc. 124 (2002), 13856, Chem. Pharm. Bull-. (1983), 4533
and Chem. Pharm. Bull. (1984), 2005, which can be used in an analogous manner for
coupling XIV with XV.
The resulting compound XVI is then, in step xv), converted into the N-oxide XVII. With
respect to step xv), reference is made to what was said for step ii) in Scheme 1 or step
x) in Scheme 3. Subsequently, in step xvi), the N-oxide XVII is, analogously to step xi)
in Scheme 3, reacted with a halogenating agent, such as POCI3 or POBr3, which gives
the 2-halo compound IX from Scheme 2. This compound is then, by the method

illustrated in Scheme 2, step viii), reacted with a phenylboronic acid compound I la or
the corresponding Grignard compound lIb, which gives the compound of the formula I.
Compounds of the formula XV are known or can be prepared by methods, known per
se, of organic chemistry (see, for example, US 6040448, WO 99/21850 and Chem.
Pharm. Bull (1983), 2254).
The reaction mixtures obtained by the methods illustrated in Schemes 1 to 4 are
worked up in the customary manner, for example by mixing with water, separating the
phases and, if appropriate, chromatographic purification of the crude products. Some
of the intermediates and end products are obtained in the form of colorless or slightly
brownish viscous oils which can be purified or freed from volatile components under
reduced pressure and at moderately elevated temperature. If the intermediates and
end products are obtained as solids, purification can also be carried out by
recrystallization or digestion.
If individual compounds I cannot be obtained by the routes described above, they can
be prepared by derivatization of other compounds I.
If the synthesis yields mixtures of isomers, a separation is generally not necessarily
required since in some cases the individual isomers can be interconverted during
work-up for use or during application (for example under the action of light, acids or
bases). Such conversions may also take place after use, for example in the treatment
of plants in the treated plant, or in the harmful fungus to be controlled.
The compounds I are suitable as fungicides. They are distinguished by an outstanding
effectiveness against a broad spectrum of phytopathogenic fungi, especially from the
classes of the Ascomycetes, Deuteromycetes, Oomycetes and Basidiomycetes. Some
are systemically effective and they can be used in plant protection as foliar and soil
fungicides.
They are particularly important in the control of a multitude of fungi on various
cultivated plants, such as wheat, rye, barley, oats, rice, maize, grass, bananas, cotton,
soya, coffee, sugar cane, vines, fruits and ornamental plants, and vegetables, such as
cucumbers, beans, tomatoes, potatoes and cucurbits, and on the seeds of these
plants.
They are especially suitable for controlling the following plant diseases:
• Alternaria species on fruit and vegetables,

• Bipolaris- and Drechslera species on cereals, rice and lawns,
• Blumeria graminis (powdery mildew) on cereals,
• Botrytis cinerea (gray mold) on strawberries, vegetables, ornamental plants and
grapevines,
• Erysiphe cichoracearum and Sphaerotheca fuliginea on cucurbits,
• Fusarium and Verticillium species on various plants,
• Mycosphaerella species on cereals, bananas and peanuts,
• Phytophthora infestans on potatoes and tomatoes,
• Plasmopara viticola on grapevines,
• Podosphaera leucothcha on apples,
• Pseudocercosporella herpotrichoides on wheat and barley,
• Pseudoperonospora species on hops and cucumbers,
• Puccinia species on cereals,
• Pyricularia oryzae on rice,
• Rhizoctonia species on cotton, rice and lawns,
• Septoria tritici and Stagnospora nodorum on wheat,
• Uncinula necatoron grapevines,
• Ustilago species on cereals and sugar cane, and
• Venturia species (scab) on apples and pears.
The compounds I are also suitable for controlling harmful fungi, such as Paecilomyces
variotii, in the protection of materials (e.g. wood, paper, paint dispersions, fibers or
fabrics) and in the protection of stored products.
The compounds I are employed by treating the fungi or the plants, seeds, materials or
soil to be protected from fungal attack with a fungicidally effective amount of the active
compounds. The application can be carried out both before and after the infection of
the materials, plants or seeds by the fungi.
The fungicidal compositions generally comprise between 0.1 and 95%, preferably
between 0.5 and 90%, by weight of active compound.
When employed in plant protection, the amounts applied are, depending on the kind of
effect desired, between 0.01 and 2.0 kg of active compound per ha.
In seed treatment, amounts of active compound of 0.001 to 0.1 g, preferably 0.01 to
0.05 g, per kilogram of seed are generally required.

When used in the protection of materials or stored products, the amount of active
compound applied depends on the kind of application area and on the desired effect.
Amounts customarily applied in the protection of materials are, for example, 0.001 g to
2 kg, preferably 0.005 g to 1 kg, of active compound per cubic meter of treated
material.
The compounds I can be converted into the customary formulations, for example
solutions, emulsions, suspensions, dusts, powders, pastes and granules. The
application form depends on the particular purpose; in each case, it should ensure a
fine and uniform distribution of the compound according to the invention.
The formulations are prepared in a known manner, for example by extending the active
compound with solvents and/or carriers, if desired using emulsifiers and dispersants.
Solvents/auxiliaries which are suitable are essentially:
- water, aromatic solvents (for example Solvesso products, xylene), paraffins (for
example mineral fractions), alcohols (for example methanol, butanol, pentanol,
benzyl alcohol), ketones (for example cyclohexanone, gamma-butyrolactone),
pyrrolidones (NMP, NOP), acetates (glycol diacetate), glycols, fatty acid
dimethylamides, fatty acids and fatty acid esters. In principle, solvent mixtures
may also be used.
- carriers such as ground natural minerals (for example kaolins, clays, talc,
chalk) and ground synthetic minerals (for example highly disperse silica,
silicates); emulsifiers such as nonionic and anionic emulsifiers (for example
polyoxyethylene fatty alcohol ethers, alkylsulfonates and arylsulfonates) and
dispersants such as lignosulfite waste liquors and methylcellulose.
Suitable surfactants are alkali metal, alkaline earth metal and ammonium salts of
lignosulfonic acid, naphthalenesulfonic acid, phenolsulfonic acid,
dibutylnaphthalenesulfonic acid, alkylarylsulfonates, alkyl sulfates, alkylsulfonates, fatty
alcohol sulfates, fatty acids and sulfated fatty alcohol glycol ethers, furthermore
condensates of sulfonated naphthalene and naphthalene derivatives with
formaldehyde, condensates of naphthalene or of naphthalenesulfonic acid with phenol
and formaldehyde, polyoxyethylene octylphenyl ether, ethoxylated isooctylphenol,
octylphenol, nonylphenol, alkylphenyl polyglycol ethers, tributylphenyl polyglycol ether,
tristearylphenyl polyglycol ether, alkylaryl polyether alcohols, alcohol and fatty
alcohol/ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl
ethers, ethoxylated polyoxypropylene, lauryl alcohol polyglycol ether acetal, sorbitol
esters, lignosulfite waste liquors and methylcellulose.

Suitable for the preparation of directly sprayable solutions, emulsions, pastes or oil
dispersions are mineral oil fractions of medium to high boiling point, such as kerosene
or diesel oil, furthermore coal tar oils and oils of vegetable or animal origin, aliphatic,
cyclic and aromatic hydrocarbons, for example toluene, xylene, paraffin,
tetrahydronaphthalene, alkylated naphthalenes or their derivatives, methanol, ethanol,
propanol, butanol, cyclohexanol, cyclohexanone, isophorone, strongly polar solvents,
for example dimethyl sulfoxide, N-methylpyrrolidone and water.
Powders, materials for spreading and dustable products can be prepared by mixing or
concomitantly grinding the active substances with a solid carrier.
Granules, for example coated granules, impregnated granules and homogeneous
granules, can be prepared by binding the active compounds to solid carriers.
Examples of solid carriers are mineral earths such as silica gels, silicates, talc, kaolin,
attaclay, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth,
calcium sulfate, magnesium sulfate, magnesium oxide, ground synthetic materials,
fertilizers, such as, for example, ammonium sulfate, ammonium phosphate,
ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree
bark meal, wood meal and nutshell meal, cellulose powders and other solid carriers.
In general, the formulations comprise from 0.01 to 95% by weight, preferably from 0.1
to 90% by weight, of the active compound. The active compounds are employed in a
purity of from 90% to 100%, preferably 95% to 100% (according to NMR spectrum).
Examples of formulations include products for dilution with water, for example
A water-soluble concentrates (SL)
10 parts by weight of a compound according to the invention are dissolved in
water or in a water-soluble solvent. As an alternative, wetters or other auxiliaries
are added. The active compound dissolves upon dilution with water;
B dispersible concentrates (DC)
20 parts by weight of a compound according to the invention are dissolved in
cyclohexanone with addition of a dispersant, for example polyvinylpyrrolidone.
Dilution with water gives a dispersion;
C emulsifiable concentrates (EC)
15 parts by weight of a compound according to the invention are dissolved in
xylene with addition of calcium dodecylbenzenesulfonate and castor oil
ethoxylate (in each case 5%). Dilution with water gives an emulsion;
D emulsions (EW, EO)

40 parts by weight of a compound according to the invention are dissolved in
xylene with addition of calcium dodecylbenzenesulfonate and castor oil
ethoxylate (in each case 5%). This mixture is introduced into water by means of
an emulsifying machine (Ultraturax) and made into a homogeneous emulsion.
Dilution with water gives an emulsion;
E suspensions (SC, OD)
In an agitated ball mill, 20 parts by weight of a compound according to the
invention are comminuted with addition of dispersants, wetters and water or an
organic solvent to give a fine active compound suspension. Dilution with water
gives a stable suspension of the active compound;
F water-dispersible granules and water-soluble granules (WG, SG)
50 parts by weight of a compound according to the invention are ground finely
with addition of dispersants and wetters and made into water-dispersible or
water-soluble granules by means of technical appliances (for example extrusion,
spray tower, fluidized bed). Dilution with water gives a stable dispersion or
solution of the active compound;
G water-dispersible powders and water-soluble powders (WP, SP)
75 parts by weight of a compound according to the invention are ground in a
rotor-stator mill with addition of dispersants, wetters and silica gel. Dilution with
water gives a stable dispersion or solution of the active compound;
and also products to be applied undiluted, for example
H dustable powders (DP)
5 parts by weight of a compound according to the invention are ground finely and
mixed intimately with 95% of finely divided kaolin. This gives a dustable product;
I granules (GR, FG, GG, MG)
0.5 part by weight of a compound according to the invention is ground finely and
associated with 95.5% carriers. Current methods are extrusion, spray-drying or
the fluidized bed. This gives granules to be applied undiluted;
J ULV solutions (UL)
10 parts by weight of a compound according to the invention are dissolved in an
organic solvent, for example xylene. This gives a product to be applied undiluted.
The active compounds can be used as such, in the form of their formulations or the
use forms prepared therefrom, for example in the form of directly sprayable solutions,
powders, suspensions or dispersions, emulsions, oil dispersions, pastes, dustable

products, materials for spreading, or granules, by means of spraying, atomizing,
dusting, spreading or pouring. The use forms depend entirely on the intended
purposes; the intention is to ensure in each case the finest possible distribution of the
active compounds according to the invention.
Aqueous use forms can be prepared from emulsion concentrates, pastes or wettable
powders (sprayable powders, oil dispersions) by adding water. To prepare emulsions,
pastes or oil dispersions, the substances, as such or dissolved in an oil or solvent, can
be homogenized in water by means of a wetter, tackifier, dispersant or emulsifier.
Alternatively, it is possible to prepare concentrates composed of active substance,
wetter, tackifier, dispersant or emulsifier and, if appropriate, solvent or oil, and such
concentrates are suitable for dilution with water.
The active compound concentrations in the ready-to-use preparations can be varied
within relatively wide ranges. In general, they are from 0.0001 to 10%, preferably from
0.01 to 1%.
The active compounds may also be used successfully in the ultra-low-volume process
(ULV), by which it is possible to apply formulations comprising over 95% by weight of
active compound, or even to apply the active compound without additives.
Various types of oils, wetters, adjuvants, herbicides, fungicides, other pesticides, or
bactericides may be added to the active compounds, if appropriate not until
immediately prior to use (tank mix). These agents can be admixed with the agents
according to the invention in a weight ratio of 1:10 to 10:1.
The compositions according to the invention can, in the use form as fungicides, also
be present together with other active compounds, e.g. with herbicides, insecticides,
growth regulators, fungicides or else with fertilizers. Mixing the compounds I or the
compositions comprising them in the application form as fungicides with other
fungicides results in many cases in an expansion of the fungicidal spectrum of activity
being obtained.
The following list of fungicides, with which the compounds according to the invention
can be used in conjunction, is intended to illustrate the possible combinations but does
not limit them:
• acylalanines, such as benalaxyl, metalaxyl, ofurace, oxadixyl,
• amine derivatives, such as aldimorph, dodine, dodemorph, fenpropimorph,
fenpropidin, guazatine, iminoctadine, spiroxamine, tridemorph,

• anilinopyrimidines, such as pyrimethanil, mepanipyrim or cyprodinyl,
• antibiotics, such as cycloheximide, griseofulvin, kasugamycin, natamycin, polyoxin
or streptomycin,
• azoles, such as bitertanol, bromoconazole, cyproconazole, difenoconazole,
dinitroconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole,
hexaconazole, imazalil, metconazole, myclobutanil, penconazole, propiconazole,
prochloraz, prothioconazole, tebuconazole, triadimefon, triadimenol, triflumizole,
triticonazole,
• dicarboximides, such as iprodione, myclozolin, procymidone, vinclozolin,
• dithiocarbamates, such as ferbam, nabam, maneb, mancozeb, metam, metiram,
propineb, polycarbamate, thiram, ziram, zineb,
• heterocyclic compounds, such as anilazine, benomyl, boscalid, carbendazim,
carboxin, oxycarboxin, cyazofamid, dazomet, dithianon, famoxadone, fenamidone,
fenarimol, fuberidazole, flutolanil, furametpyr, isoprothiolane, mepronil, nuarimol,
probenazole, proquinazid, pyrifenox, pyroquilon, quinoxyfen, silthiofam,
thiabendazole, thifluzamide, thiophanate-methyl, tiadinil, tricyclazole, triforine,
• copper fungicides, such as Bordeaux mixture, copper acetate, copper oxychloride,
basic copper sulfate,
• nitrophenyl derivatives, such as binapacryl, dinocap, dinobuton, nitrophthal-
isopropyl,
• phenylpyrroles, such as fenpiclonil or fludioxonil,
• sulfur,
• other fungicides, such as acibenzolar-S-methyl, benthiavalicarb, carpropamid,
chlorothalonil, cyflufenamid, cymoxanil, diclomezine, diclocymet, diethofencarb,
edifenphos, ethaboxam, fenhexamid, fentin acetate, fenoxanil, ferimzone,
fluazinam, fosetyl, fosetyl-aluminum, iprovalicarb, hexachlorobenzene,
metrafenone, pencycuron, propamocarb, phthalide, tolclofos-methyl, quintozene,
zoxamide,
• strobilurins, such as azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl,
metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin or trifloxystrobin,
• sulfenic acid derivatives, such as captafol, captan, dichlofluanid, folpet, tolylfluanid,
• cinnamides and analogous compounds, such as dimethomorph, flumetover or
flumorph.
Synthesis examples
The procedures described in the synthesis examples below were used to prepare

further compounds by appropriate modification of the starting compounds. The
compounds thus obtained are listed in the tables below, together with physical data.
The following abbreviations are used in the examples:
m.p.: melting point;
MtBE: methyl tert-butyl ether;
EtOH: ethanol.
The following abbreviations are used in connection with the 1H-NMR data:
s: singlet; d: doublet; t: triplet; m: multiplet
Example 1:2-(5-methyl-6-phenylpyridin-2-yl)-6,7,8,9-tetrahydro-5H-
cycloheptapyrimidine

1.1 3-methyl-2-phenylpyridine
2.1 g (17.2 mmol) of phenylboronic acid and 4.3 g of potassium carbonate in
20 ml of water were added successively to a solution of 2.0 g (11.6 mmol) of
2-bromo-3-methylpyridine in 80 ml of tetrahydrofuran. After addition of 300 mg
of tetrakis(triphenylphosphine)palladium(0), the mixture was stirred under reflux
for 8 hours. The reaction solution was poured into ice-water and extracted with
MtBE. The combined organic phases were dried, the solvent was removed
under reduced pressure and the residue was chromatographed on silica gel
using cyclohexane/MtBE (9:1). This gave 0.8 g of product.
1H-NMR (δ,CDCI3,): 2.5 (s); 7.2 (m); 7.35-7.6 (m) and 8.5 (m)
1.2 3-methyl-2-phenylpyridine N-oxide
25 g (147.7 mmol) of 3-methyl-2~phenylpyridine were initially charged in 150 ml
of dichloromethane. At 5°C, 51.6 g (294 mmol) of 3-chloroperoxybenzoic acid
was added a little at a time, and the mixture was stirred at 5°C for 2 hours and
at 23°C for 18 hours. The solvent was removed and the residue was then
chromatographed on silica gel using cyclohexane/MtBE (1:1), which gave 25 g
of product.

m.p.: 163-165°C.
1H-NMR (δ, CDCI3,): 2.0 (s); 7.1-7.6 (m); 8.3 (m).
1.3 5-methyl-6-phenylpyridine-2-carbonitrile
14.9 g (150 mmol) of trimethylsilyl cyanide were added to a solution of 25 g
(118.2 mmol) of the compound prepared in example 1.2 in 150 ml of
dichloromethane, and the mixture was stirred at room temperature for 30
minutes. A solution of 16.2 g (150 mmol) of dimethylcarbamoyl chloride was
then added over a period of 45 min, and the mixture was stirred at 23°C for 18
hours. 70 ml of water and 40 ml of 1 N aqueous sodium hydroxide solution
were carefully added to the reaction solution. The pH was then adjusted to 8
using solid sodium carbonate. The organic phase was separated off, washed
with water and dried. Removal of the solvent gave, after chromatography on
silica gel using cyclohexane/MtBE (3:2), 19.9 g of the title compound as an oil.
1H-NMR (δ,CDCI3): 2.45 (s); 7.4-7.8 (m)
1.4 5-methyl-6-phenylpyridine-2-carboxamidine hydrochloride
2.34 g of a 30% strength solution of sodium methoxide in methanol were added
to a solution of 5.0 g (26 mmol) of 5-methyl-6-phenylpyridine-2-carbonitrile from
example 1.3 in 65 ml of methanol, and the mixture was stirred at 23°C for 7
hours. 1.5 g of ammonium chloride were then added, and the mixture was
stirred at 23°C for a further 8 hours. After removal of the solvent, MtBE was
added and the product was filtered off, which gave 5.4 g of the title compound
as a yellowish solid.
1H-NMR (δ, DMSO): 7.5 (m); 7.7 (m); 8.2 (m); 8.3 (m); 9.6 (m).
1.5 2-(5-methyl-6-phenylpyridin-2-yl)-6,7,8,9-tetrahydro-5H-cycloheptapyrimidine
1.3 g of sodium methoxide (30% strength solution in methanol) were added to a
solution of 1.5 g (6.1 mmol) of the compound prepared in example 1.4 in 30 ml
of methanol. After 30 min, 1.2 g (7.3 mmol) of 2-dimethylamino-
methylenecycloheptanone [prepared according to Tetrahedron Letters (1986),
2567] were added, and the mixture was heated at reflux for 2 hours. The
reaction solution was then partitioned between water and MtBE. The organic
phase was separated off. The solvent was removed under reduced pressure
and the residue was chromatographed on silica gel using cyclohexane/MtBE
(1:1). This gave 0.72 g of the title compound.

m.p.: 151-154X
Example 2: 4-[3-methyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)pyridin-2-yl]benzaldehyde

2.1 6-bromo-5-methylpyridine-2-carboxamidine hydrochloride
2.2 g of a 30% strength solution of sodium methoxide in methanol were added
to 4.90 g (25 mmol) of 6-bromo-5-methylpyridine-2-carbonitrile [prepared
according to US 2003/0087940 A1 or Bioorg. Med. Chem. Lett. (2003), 1571-
1574] in 60 ml of methanol, and the mixture was stirred at 23°C for 7 hours.
1.5 g of ammonium chloride were then added, and the mixture was stirred at
23°C for a further 8 hours. After removal of the solvent, MtBE was added to the
residue and the solid was filtered off. This gave 4.2 g of the title compound as a
white solid which was reacted further without purification.
2.2 2-(6-bromo-5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
3.6 g of sodium methoxide (30% strength solution in methanol) were added to a
solution of 4.2 g (7 mmol) of the compound prepared in example 2.1 in 100 ml
of methanol. After 30 min, 3.1 g (20 mmol) of 2-dimethylamino-
methylenecyclohexanone [prepared, for example, according to Tetrahedron 50
(7) (1994), 2255-64; Synthetic Communications 28(10) (1998), 1743-1753 or
Tetrahedron Letters 27(23) (1986), 2567-70] were added, and the mixture was
heated at reflux for 2 hours. The reaction solution was then partitioned between
water and MtBE. The organic phase was separated off, the solvent was
removed under reduced pressure and the residue was chromatographed on
silica gel using cyclohexane/MtBE (1:1). This gave 2.2 g of the title compound.
1H-NMR (δ,CDCI3,): 1.8-2.0 (m); 2.5 (s); 2.8 (m); 3.0 (m)
2.3 4-[3-methyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)pyridin-2-yl]benzaldehyde

0.24 g of 4-formylphenylboronic acid and 0.2 g of sodium carbonate in 3 ml of
water were added successively to a solution of 0.2 g of the compound prepared
in example 2.2 in 20 ml of ethylene glycol dimethyl ether. After addition of about
50 mg of tetrakis(triphenylphosphine)palladium(0), the mixture was stirred
under reflux for 9 hours. A further 0.2 g of 4-formylphenylboronic acid was then
added, and the mixture was allowed to react under reflux for a further 10 hours.
The reaction solution was then partitioned between water and MtBE. The
organic phase was separated off, the solvent was removed under reduced
pressure and the residue was chromatographed on silica gel using
cyclohexane/MtBE (1:1). This gave 35 mg of the title compound of m.p. 151-
154°C.
1H-NMR (δ,CDCI3,): 1.8-2.0 (m, 4 H); 2.4 (s, 3H); 2.8 (m, 2H); 3.0 (m, 2H); 7.8
(m, 3H); 8.0 (m, 2H); 8.4 (m, 1H); 8.6 (s, 1H); 10.1 (s, 1H).
Example 3: 2-(5-methoxy-6-phenylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline

3.1 5-methoxy-6-phenylpyridine-2-carbonitrile
2.1 g of 3-methoxy-2-phenylpyridine [prepared according to Bulletin de la
Societe Chimique de France (1974), 1112-16] were initially charged in 60 ml of
dichloromethane. At 5°C, 2.4 g of 3-chloroperoxybenzoic acid were added a
little at a time, and the mixture was stirred at 5°C for 2 hours and at 23°C for 18
hours. The solvent was removed and the residue was then chromatographed
on silica gel using methyl tert-butyl ether (MtBE), which gave 1.4 g of 3-
methoxy-2-phenylpyridine N-oxide as a crude product in the form of an oil.
The crude product was dissolved in 80 ml of dichloromethane, and 0.9 g of
trimethylsilyl cyanide was added dropwise over a period of 5 min and the
mixture was stirred at 23°C for 30 minutes. Over a period of 45 min, a solution
of 0.95 g of dimethylcarbamoyl chloride in 10 ml of dichloromethane was then
added dropwise, and the mixture was stirred at 23°C for 18 hours. 40 ml of

water and 10 ml of 1 N aqueous sodium hydroxide solution were added
carefully to the reaction solution. The pH was then adjusted to 8 using solid
sodium carbonate and the organic phase was separated off, washed with water
and dried. Removal of the solvent gave, after chromatography on silica gel
using cyclohexane/MtBE (3:2), 0.2 g of 5-methoxy-6-phenylpyridine-2-
carbonitrile as an oil.
1H-NMR (δ,CDCI3,): 3.9 (s); 7.5 (m); 7.7 (m) and 7.9 (m).
3.2 2-(5-methoxy-6-phenylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
The title compound can be prepared analogously to steps 1.4 and 1.5 of
example 1 using, instead of 2-dimethylaminomethylenecycloheptanone, the
corresponding hexanone.
Example 4: 2-(5-chloro-6-phenylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline

4.1 2-bromo-2-chloropyridine
60 ml of a 33% strength solution of hydrogen bromide in acetic acid were
added to 6.3 g of 2,3-dichloropyridine in 50 ml of acetic acid, and the mixture
was heated under reflux for 8 hours. A further 42 ml of hydrogen bromide
solution were then added. After 6 hours, the reaction had gone to completion.
The reaction solution was poured into ice-water and extracted with methylene
chloride. The combined organic phases were washed with water and dried, and
the solvent was removed under reduced pressure. This gave 8.7 g of product in
the form of an oil.
1H-NMR (δ,CDCI3,): 7.2 (m); 7.8 (m) and 8.3 (m).
4.2 3-chloro-2-phenylpyridine

2.35 g of phenylboronic acid and 4.8 g of sodium carbonate in 30 ml of water
were added successively to a solution of 2.5 g of 2-bromo-3-methoxypyridine in
80 ml of tetrahydrofuran. After addition of 300 mg of tetrakis(triphenyl-
phosphine)palladium(O), the mixture was stirred under reflux for 8 hours.
Another 2 g of phenylboronic acid, 2 g of sodium carbonate and 100 mg of
tetrakis(triphenylphosphine)palladium(0) were then added, and the mixture was
heated under reflux for a further 6 hours. The reaction solution was poured into
ice-water and extracted with MtBE. The combined organic phases were dried,
the solvent was removed under reduced pressure and the residue was
chromatographed on silica gel using cyclohexane/MtBE (9:1). This gave 2.2 g
of product in the form of an oil.
1H-NMR (δ, CDCI3,): 7.3 (m); 7.5 (m); 7.8 (m) and 8.6 (m).
4.3 3-chloro-2-phenylpyridine 1-oxide
2.2 g of 3-chloro-2-phenylpyridine were initially charged in 80 ml of
dichloromethane. At 5°C, 3.0 g of 3-chloroperoxybenzoic acid were added a
little at a time to the mixture, and the mixture was stirred at 5°C for 2 hours and
at 23°C for 18 hours. The solvent was removed and the residue was then
chromatographed on silica gel using MtBE, which gave 1.9 g of product in the
form of an oil.
1H-NMR (δ,CDCI3,): 7.2 (m); 7.4-7.6 (m) and 8.3 (m).
4.4 5-chloro-6-phenylpyridine-2-carbonitrile
0.74 g of dimethyl sulfate was added to 1.2 g of 3-chloro-2-phenylpyridine
1-oxide in 5 ml of DMF, and the mixture was allowed to react at 60°C for 7
hours. After cooling to 23°C, this solution was added dropwise to 0.38 g of
potassium cyanide in 10 ml of DMF and stirred at 23°C for 18 hours. The
mixture was subsequently partitioned between MtBE and water, the organic
phase was dried, the solvent was removed under reduced pressure and the
residue was chromatographed on silica gel using cyclohexane/MtBE (3:2). This
gave 0.30 g of product.
1H-NMR (δ, CDCI3,): 7.5 (m); 7.6 (m); 7.7 (m) and 7.9 (m).
4.5 2-(5-chloro-6-phenylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline

The title compound can be prepared analogously to steps 1.4 and 1.5 of
example 1 using, instead of 2-dimethylaminomethylenecycloheptanone, the
corresponding hexanone.
Example 5: 4-[3-methyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)pyridin-2-yl]benzonitrile
5.1 6-chloro-5-methylpyridine-2-carbonitrile
2.3 g of 5-methylpyridine-2-carbonitrile were initially charged in 80 ml of
dichloromethane. At 5°C, 5.4 g of 3-chloroperoxybenzoic acid were added a
little at a time, and the mixture was stirred at 5°C for 2 hours and at 23°C for 18
hours. After removal of the solvent, the residue was chromatographed on silica
gel using MtBE, which gave 0.8 g of 2-cyano-5-methylpyridine 1-oxide.
0.8 g of 2-cyano-5-methylpyridine 1-oxide was, together with 25 ml of
phosphorus oxychloride, heated under reflux for 5 hours. After the reaction had
gone to completion, the excess phosphorus oxychloride was removed under
reduced pressure. The residue was taken up in methylene chloride, added, with
ice-cooling, to water and adjusted to pH 12 using 3 N aqueous sodium
hydroxide solution. The organic phase was separated off and dried, and the
solvent was removed under reduced pressure. This gave 0.8 g of product.
1H-NMR (δ,CDCI3,): 2.4 (s); 7.6 (m) and 7.7 (m).
5.2 2-(6-chloro-5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
Analogously to example 1.4, 6-chloro-5-methylpyridine-2-carbonitrile was
converted into the 6-bromo-5-methylpyridine-2-carboxamidine hydrochloride.
Analogously to example 2.2, this was then used to prepare 2-(6-chloro-5-
methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline.
1H-NMR (δ,CDCI3,): 8.5 (s); 8.3 (m); 7.7 (m); 3.0 (m); 2.8 (m); 2.4 (s); 1.8-2.0
(m).
5.3 2-(6-bromo-5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
8 ml of a 33% strength solution of hydrogen bromide in acetic acid were added
to 1 g of 2-(6-chloro-5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline in 8 ml
of acetic acid, and the mixture was heated under reflux for 10 hours. The
reaction solution was diluted with water, adjusted to pH 9 using 3 N aqueous
sodium hydroxide solution and extracted with MtBE. The combined organic

phases were washed with water and dried, and the solvent was removed under
reduced pressure. This gave 0.9 g of product.
m.p.: 125-128°C
5.4 4-[3-methyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)pyridin-2-yl]benzonitrile
The title compound was prepared analogously to example 2.3 by reacting 2-(6-
bromo-5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline with 4-cyanophenyl-
boronic acid.
m.p.: 178-182°C
Preparation examples for starting materials:
Preparation example 1: 2-(4-fluorophenyl)-3-methylpyridine
0.70 g of [1,4-bis(diphenylphosphino)butane]palladium(ll) chloride was added to
a solution of 20.0 g of 2-bromo-3-methylpyridine in 200 ml of tetrahyrdofuran.
After 10 min, 128 ml of a 2 molar solution of 4-fluorophenylmagnesium bromide
in tetrahydrofuran were added dropwise, and the mixture was heated under
reflux for 5 hours. After addition of a further 30 ml of 4-fluorophenylmagnesium
bromide solution, the reaction solution was, after 1 hour, added with ice-cooling
to aqueous ammonium chloride solution and extracted with ethyl acetate. The
combined organic phases were dried, the solvent was removed under reduced
pressure and the residue was chromatographed on silica gel using
cyclohexane/MtBE (9:1). This gave 17.8 g of 2-(4-fluorophenyl)-3-
methylpyridine as an oil.
Preparation example 2: 2-(6-chloro-5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
a) 5-methylpyhdine-2-carboxamidine hydrochloride
The compound was prepared from 2-cyano-5-methylpyridine under the
conditions given for example 1.4.
1H-NMR (δ, DMSO): 2.4 (m); 7.9 (m); 8.3 (m); 8.6 (m).
b) 2-(5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
The compound was prepared from 2-methylpyridine-2-carboxamidine
hydrochloride under the conditions given for example 2.2.

1H-NMR (δ,CDCI3,): 1.9 (m); 2.4 (s); 2.7 (m); 3.0 (m); 7.6 (m); 8.4 (m); 8.5 (m);
8.7 (m).
c) 2-(5-methyl-1-oxypyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
1.0 g of 2-(5-methylpyridin-2-yl)-5,6,7I8-tetrahydroquinazoline was initially
charged in 10 ml of dichloromethane. At 5°C, 1.4 g of 3-chloroperoxybenzoic
acid were added a little at a time, and the mixture was stirred at 5°C for 2 hours
and at 23°C for 18 hours. After removal of the solvent, the residue was
chromatographed on silica gel using MtBE/EtOH (5:2), which gave 0.75 g of
product.
1H-NMR (δ,CDCI3,): 8.6 (s); 8.2 (s); 7.5 (m); 7.1 (m); 3.0 (m); 2.8 (m); 2.4 (m);
1.7-1.9 (m).
d) 2-(6-chloro-5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
0.75 g of 2-(5-methylpyridin-2-yl)-5,6,7,8-tetrahydroquinazoline were, together
with 10 ml of phosphorus oxychloride, heated under reflux for 10 hours. After
the reaction had gone to completion, the excess phosphorus oxychloride was
removed under reduced pressure. The residue was taken up in methylene
chloride and, with ice-cooling, added to water. The organic phase was
separated off and dried, and the solvent was removed under reduced pressure.
The residue was chromatographed on silica gel using cydohexane/MtBE (4:1).
This gave 80 mg of product.
The compounds of the formula I listed in table B below were prepared by the
procedures given above.











Test of the fungicidal activity:
For the use examples 1 to 5 the active compounds were prepared separately as a
stock solution with 0.25% by weight of active compound in acetone or DMSO. 1% by
weight of the emulsifier Wettol® EM 31 (wetting agent having emulsifying and
dispersing action based on ethoxylated alkylphenols) was added to this solution, and
the solution was diluted with water to the desired concentration.
For use examples 6 to 9, the active compounds were prepared as a stock solution
comprising 25 mg of active compound which was made up to 10 ml using a mixture of
acetone and/or DMSO and the emulsifier Uniperol® EL (wetting agent having
emulsifying and dispersing action based on ethoxylated alkylphenols) in a volume ratio
of solvent/emulsifier of 99 to 1. This solution was then made up to 100 ml using water.
This stock solution was diluted with the solvent/emulsifier/water mixture described to
the active compound concentration given below.
Use example 1 - Activity against early blight caused by Alternaria solani
Leaves of tomato plants of the cultiva "Goldene Prinzessin" were sprayed to runoff point
with an aqueous suspension having the concentration of active compounds stated below.
The next day, the treated plants were infected with a spore suspension of Alternaria
solani in a 2% aqueous biomalt solution having a density of 0.17 x 106 spores/ml. The
test plants were then placed in a water-vapor-saturated chamber at temperatures of from
20 to 22°C. After 5 days, the early blight on the untreated, but infected plants had
developed to such an extent that the infection could be determined visually.

In this test, the plants which had been treated with 250 ppm of the active compounds
from examples 1,6,7,9 and 11 howed no infection, whereas the untreated plants were
90% infected. The plants which, for comparison, had been treated under the same
conditions with 2-(5-methyl-6-(4-fluorophenyl)pyridin-2-yl)-5,6,7,8-tetrahydroquinazoline
(compound according to EP-A 259 139) showed an infection of 80%.
Use example 2 - Activity against gray mold on bell pepper leaves caused by Botrytis
cinerea with protective application
Bell pepper leaves of the cultiva "Neusiedler Ideal Elite" were, after 2 to 3 leaves had
become well developed, sprayed to runoff point with an aqueous suspension having the
concentration of active compounds stated below. The next day, the treated plants were
inoculated with an aqueous spore suspension of Botrytis cinerea in a 2% aqueous
biomalt solution having a density of 1.7 x 106 spores/ml. The plants were then placed in a
climatized chamber at temperatures between 22 and 24°C and at high atmospheric
humidity. After 5 days, the extent of the fungal infection was determined visually by the
infected leaf area.
In this test, the plants which had been treated with 250 ppm of the active compounds
from examples 6, 7 and 11 showed no infection. whereas the untreated plants were
90% infected.
Use example 3 - Activity against mildew of wheat caused by Erysiphe [syn. Blumeria]
graminis forma specialis. tritici
Leaves of potted wheat seedlings of the cultiva "Kanzler" were sprayed to runoff point
with an aqueous suspension having the concentration of active compounds stated below.
24 h after the spray coating had dried on, the leaves were dusted with the spores of
mildew of wheat (Erysiphe [syn. Blumeria] graminis forma specialis. tritici). The plants
were then placed in a greenhouse at temperatures between 20 and 24°C and at 60-90%
relative atmospheric humidity. After 7 days, the extent of the fungal infection was
determined visually by the infected leaf area.
In this test, the plants which had been treated with 250 ppm of the active compound
from example7 were only slightly infected (20%), whereas the untreated plants were
90% infected. The plants which, for the purpose of comparison, had been treated
under the same conditions with 2-(5-methyl-6-(4-fluorophenyl)pyridin-2-yl)-5,6,7,8-
tetrahydroquinazoline (compound according to EP-A 259 139) showed an infection of
80%.

Use example 4 - Activity against peronospora of grapevines caused by Plasmopara
viticola
Leaves of potted grapevines were sprayed to runoff point with an aqueous suspension
having the concentration of active compounds stated below. The next day, the
undersides of the leaves were inoculated with an aqueous sporangia suspension of
Plasmopara viticola. The plants were then initially placed in a water-vapor-saturated
chamber for 48 h and then in a greenhouse at temperatures between 20 and 30°C. After
this period of time, the plants were, to promote sporangial eruption, again placed in the
water-vapor-saturated chamber for 16 h. The extent of the development of the infection
on the undersides of the leaves was then determined.
In this test, the plants which had been treated with 63 ppm of the active compound
from example 7 showed no infection, whereas the untreated plants were 90% infected.
The plants which, for the purpose of comparison, had been treated under the same
conditions with 2-(methyl--6-(4-fluorophenyl)pyridin-2-yl)-5,6,7,8-tetrahydro-
quinazoline (compound according to EP-A 259 139) showed an infection of 70%.
Use example 5 - Curative activity against brown rust of wheat caused by Puccinia
recondita
Leaves of potted wheat seedlings of the cultivar "Kanzler" were inoculated with a spore
suspension of brown rust (Puccinia recondita). The pots were then placed in a chamber
at high atmospheric humidity (90 to 95%) and 20 to 22°C for 24 hours. During this time,
the spores germinated and the germ tubes penetrated into the leaf tissue. The next day,
the infected plants were sprayed to runoff point with an aqueous suspension having the
active compound concentration stated below. The suspension or emulsion had been
prepared as described above. After the spray coating had dried, the test plants were
cultivated in a greenhouse at temperatures between 20 and 22°C and at 65 to 70%
relative atmospheric humidity for 7 days. The extent of the rust fungus development on
the leaves was then determined.
In this test, the plants which had been treated with 250 ppm of the active compound
from example 9 showed only minor infection (20% infection), whereas the untreated
plants were 90% infected. The plants which, for comparison, had been treated under
the same conditions "with 2-(5-methyl-6-(4-fluorophenyl)pyridin-2-yl)-5,6,7,8-tetrahydro-
quinazoline (compound according to EP-A 259 139) showed an infection of 50%.
Use example 6 - Activity against early blight caused by Alternaria solani
Leaves of potted tomato plants of the cultivar "Goldene Kdnigin" were sprayed to runoff
point with an aqueous suspension having the active compound concentration stated

below. The next day, the leaves were infected with an aqueous spore suspension of
Alternaria solani in a 2% strength biomalt solution having a density of 0.17 x 106
spores/ml. The plants were then placed in a water vapor-saturated chamber at
temperatures of 20 to 22°C. After 5 days, the disease on the untreated but infected plants
had developed to such an extent that the infection could be determined visually.
In this test, the plants which had been treated with 63 ppm of the active compounds
from examples 9, 13, 16, 17, 18, 72, 73, 74, 75, 76, 78, 79, 82, 84, 85, 86, 87, 88, 89, 90,
91, 92, 93 and 95 showed an infection of at most 20%, whereas the untreated plants
were 90% infected.
Use example 7 - Activity against net blotch of barley caused by Pyrenophora teres with 1 o
days protective application
Leaves of potted barley seedlings were sprayed to runoff point with an aqueous
suspension having the active compound concentration stated below. 24 hours after the
spray coating had dried, the plants were inoculated with an aqueous spore suspension of
Pyrenophora [syn. Drechslera] teres, the net blotch pathogen. The test plants were then
placed in the green house at temperatures between 20 and 24°C and 95 to 100% relative
atmospheric humidity. After 6 days, the extent of the development of the disease was
determined visually in % by the infected leaf area.
In this test, the plants which had been treated with 63 ppm of the active compounds from
examples 4, 9, 13, 16, 17, 18, 21, 23, 26, 27, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82,
83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 98, 102, 105, 119, 120, 121, 122,
124, 126, 127, 128, 136, 137, 138, 139, 143, 146, 151, 157 und 159 showed an infection
of at most 20%, whereas the untreated plants were 90% infected.

Use example 8 - Activity against grey mold on bell pepper leaves caused by Botrytis
cinerea, protective application
Bell pepper leaves of the cultivar "Neusiedler Ideal Elite" were, after 2 to 3 leaves were
well developed, sprayed to runoff point with an aqueous suspension having the active
compound concentration stated below. The next day, the treated plants were inoculated
with a spore suspension of Botrytis cinerea, comprising 1.7 * 106 spores/ml in a 20%
strength aqueous biomalt solution. The test plants were then placed in a dark climatized
chamber at temperatures between 22 and 24°C, and high atmospheric humidity. After 5
days, the extent of the fungal infection was determined visually in % by the infected leaf
area.

In this test, the plants which had been treated with 63 ppm of the active compounds
from examples 4, 26, 80, 83 and 94 showed an infection of at most 20%, whereas the
untreated plants were 90% infected".
Use example 9 - Activity against late blight on tomatoes caused by Phytophthora
infestans with protection treatment
Leaves of potted tomato plants were sprayed to runoff point with an aqueous suspension
having the active compound concentration stated below. The next day, the leaves were
infected with an aqueous sporangia suspension of Phytophthora infestans. The plants
were then placed in a water vapor-saturated chamber at temperatures between 18 and
20°C. After 6 days, the late blight on the untreated but infected control plants had
developed to such an extent that the infection could be determined visually in %.
In this test, the plants which had been treated with 63 ppm of the active compounds from
examples 98, 117, 118, 119, 120, 122, 124, 125, 126, 127, 128, 129, 130, 133, 134, 135,
136, 138, 139, 141, 142, 143, 144, 145, 146, 147, 150, 151, 152, 156, 157 and 159
showed an infection of at most 20%, whereas the untreated plants were 90% infected.


We claim:
1. A 2-(pyridin-2-yl)pyrimidine compound of the formula I

in which:
k is 0, 1, 2 or 3;
m is 0, 1, 2, 3,4 or 5;
n is 1, 2, 3, 4 or 5;
R1 independently of one another are halogen, OH, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-
alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl,
C2-C4-alkynyl, C3-C8-cycloalkyl, C1-C4-alkoxy-C1-C4-alkyl, amino, phenoxy which is optionally
substituted by halogen or C1-C4-alkyl, NHR, NR2, C(Ra)=N-ORb, S(=O)pA1 or C(=O)A2, where
p, R, Ra, Rb, A1 and A2 are as defined below:
R is C1-C4-alkyl or C1-C4-alkylcarbonyl,
Ra is hydrogen or C1-C4-alkyl,
Rb is C1-C4-alkyl, C3-C4-alkenyl or C3-C4-alkynyl,
p is 0, 1 or 2,
A1 is C1-C4-alkyl or for p = 2 also NH2, C1-C4-alkylamino or di-(C1-C4-alkyl)amino, and
A2 is hydrogen, hydroxy!, C1-C4-alkyl, C1-C4-alkylamino, di-(C1-C4-alkyl)amino, C2-C4-
alkenyl, C1-C4-alkoxy or
C1-C4-haloalkoxy;
or two radicals R1 attached to adjacent carbon atoms together may also be a group -O-Alk-O-
where Alk is straight-chain or branched C1-C4-alkylene and where 1, 2, 3 or 4 hydrogen atoms
may also be replaced by halogen;
R2 is C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, hydroxyl, halogen, CN or NO2;
where R2 may also be hydrogen or C1-C4-alkyl if at least one of the following conditions
is met:
n is 3, 4 or 5,
k is 1, 2 or 3;

and
R3 is C1-C4-alkyl;
or an agriculturally acceptable salt of the compound I.
2. The compound of the formula I as claimed in claim 1, in which R2 is C1-C4-haloaIkyl, C1-C4-
alkoxy, C1-C4-haloalkoxy, halogen, CN or NO2.
3. The compound of the formula I as claimed in claim 2, in which R2 is C1-C4-alkoxy, C1-C4-
haloalkoxy or halogen.
4. The compound of the formula I as claimed in claim 2 or 3, in which n is 1, 2 or 3.
5. The compound of the formula I as claimed in any of claims 1 to 4, in which n is 3, 4 or 5 and
in particular 3.
6. The compound of the formula I as claimed in any of the preceding claims, in which m is 0, 1,
2 or 3.
7. The compound of the formula I as claimed in any of the preceding claims, in which the R1 is
halogen, CN, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy or C1-C4-haloalkoxy.
8. The compound of the formula I as claimed in any of claims 1 to 6, in which one of the
radicals R1 is a group C(Ra)=N-ORb.
9. The compound of the formula I aas claimed in any of the preceding claims, in which the
group

in which # is the point of attachment to the pyridine ring, is a radical of the formula P

in which
R" is hydrogen, fluorine, chlorine, CH3, OCH3, OCHF2, OCF3 or CF3;
R'12, R14 independently of one another are hydrogen, chlorine, fluorine, CH3, OCH3, OCHF:,
OCF3 or CF3, where one of the radicals R12 and R14 may also be NO2, C(O)CH3 or COOCH3;
R13 is hydrogen, fluorine, chlorine, cyano, OH, CHO, NO;, NH;, methylamino, dimethylamino,
diethylamino, C1-C4-alkyl, C3-C8-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-haloalkyl, C1-
C4-haloalkoxy, CO(A2), in which A2 is C1-C4-alkyl or C1-C4-alkoxy, or a group C(Ra)=NORb, in
which Ra is hydrogen or methyl and Rb is C1-C4-alkyl, propargyl or allyl, or R12 and R13 together

form a group O-CH2-O; and
Rb is hydrogen, fluorine, chlorine or C1-C4-ralkyl.
10. The compound of the formula I as claimed in claim 9, in which at least one of the radicals R",
R12, R13, R14 or R15 is different from hydrogen.
11. A composition suitable for controlling harmful fungi, which composition comprises a solid or
liquid carrier and a compound of the formula 1 as claimed in any of claims 1 to 10 and/or an
agriculturally acceptable salt of I.


The invention relates to
2-(pyridin-2-yl)-pyrimidine compounds of general
formula (I) and their use for controlling pathogenic
fungi and as plant protection products that, as an active
constituent, contain compounds of this type, whereby:
k represents 0, 1, 2, 3; m represents 0, 1, 2, 3, 4 or 5; n
represents 1, 2, 3, 4 or 5; R1 , independent of one another,
represents halogen, OH, CN, NO2, C1-C4 alkyl, C1-C4 alkyl
halide, C1-C4 alkoxy, C1-C4 alkoxy halide, C2-C4 alkenyl,
C2-C4 alkynyl, C3-C8 cycloalkyl, C1-C4 alkoxy-C1-C4
alkyl, amino, phenoxy, which is optionally substituted by
halogen or C1-C4 alkyl, NHR, NR2, C(Ra)=N-ORb, S(=O)pAl or C(=O)A2, or two radicals R1 bound to adjacent carbon atoms can,
together, also represent a group -O-Alk-O-, wherein Alk represents a linear or branched C1-C4 alkylene, and 1, 2, 3 or 4 hydrogen
atoms can also be replaced by halogen; R2 represents C1-C4 alkyl halide, C1-C4 alkoxy, C1-C4 alkoxy halide, hydroxy, halogen, CN
or NO2; whereby R2 can also represent hydrogen or C1-C4 alkyl when at least one of the three following conditions is fulfilled: n
represents 3, 4 or 5; k represents 1, 2 or 3; if m is not equal to 0, at least one of the radicals R1 represents a radical that differs from
halogen, C1-C4 alkyl, C1-C4 alkoxy and C1-C4 alkyl halide, and; R3 represents C1-C4 alkyl.

Documents:

00132-kolnp-2007 abstract.pdf

00132-kolnp-2007 assignment.pdf

00132-kolnp-2007 claims.pdf

00132-kolnp-2007 correspondence others.pdf

00132-kolnp-2007 correspondence-1.1.pdf

00132-kolnp-2007 description(complete).pdf

00132-kolnp-2007 form-1.pdf

00132-kolnp-2007 form-3.pdf

00132-kolnp-2007 form-5.pdf

00132-kolnp-2007 international publication.pdf

00132-kolnp-2007 international search authority report.pdf

00132-kolnp-2007 pct form.pdf

00132-kolnp-2007 priority document.pdf

00132-kolnp-2007-claims-1.1.pdf

00132-kolnp-2007-correspondence-1.2.pdf

00132-kolnp-2007-form 13.pdf

00132-kolnp-2007-form-18.pdf

132-kolnp-2007-assignment.pdf

132-kolnp-2007-correspondence.pdf

132-kolnp-2007-examination report.pdf

132-KOLNP-2007-FORM 13.1.1.pdf

132-kolnp-2007-form 13.pdf

132-kolnp-2007-form 18.pdf

132-kolnp-2007-form 3.pdf

132-kolnp-2007-form 5.pdf

132-KOLNP-2007-FORM-27.pdf

132-kolnp-2007-gpa.pdf

132-kolnp-2007-granted-abstract.pdf

132-kolnp-2007-granted-claims.pdf

132-kolnp-2007-granted-description (complete).pdf

132-kolnp-2007-granted-form 1.pdf

132-kolnp-2007-granted-specification.pdf

132-KOLNP-2007-OTHERS PATENT DOCUMENTS.pdf

132-kolnp-2007-others.pdf

132-kolnp-2007-reply to examination report.pdf

132-kolnp-2007-translated copy of priority document.pdf

abstract-00132-kolnp-2007.jpg


Patent Number 247503
Indian Patent Application Number 132/KOLNP/2007
PG Journal Number 15/2011
Publication Date 15-Apr-2011
Grant Date 12-Apr-2011
Date of Filing 10-Jan-2007
Name of Patentee BASF AKTIENGESELLSCHAFT
Applicant Address 67056 LUDWIGSHAFEN
Inventors:
# Inventor's Name Inventor's Address
1 GRAMMENOS WASSILIOS ALEXANDER-FLEMING-STR. 13, 67071 LUDWIGSHAFEN
2 BLETTNER CARSTEN RICHARD-WAGNER-STR. 48, 68165 MANNHEIM
3 GEWEHR MARKUS GOETHESTR. 21, 56288 KASTELLAUN
4 HUNGER UDO KURT-SCHUMACHER-STRASSE 43, 55124 MAINZ
5 MULLER BERND STOCKINGERSTRASSE 7, 67227 FRANKENTHAL
6 RHEINHEIMER JOACHIM MERZIGER STRASSE 24, 67063 LUDWIGHSAFEN
7 SCHAFER PETER ROMERSTRASSE 1, 67308 OTTERSHEIM
8 SCHIEWECK FRANK LINDENWEG 4, 67258 HESSHEIM
9 SCHWOGLER ANJA HEINRICH-LANZ-STR. 3, 68165 MANNHEIM
10 SCHOFL ULRICH ERLENSTR. 8, 68782 BRUHL,
11 KOHLE HARALD AM BUSCHEL 13, 67273 BOBENHEIM
12 STRETHMANN SIEGFRIED DONNERSBERGSTR 9, 67117 LIMBURGERHOF
13 SCHERER MARIA HERMANN-JURGENS-STR. 30, 76829 GODRAMSTEIN
14 STIERL REINHARD JAHNSTR 8, 67251 FREINSHEIM
15 RETHER JAN ST.-MARIEN-PLATZ 23, 67655 KAISERSLAUTERN
16 GROTE THOMAS IM HOHNHAUSEN 18, 67157 WACHENHEIM
PCT International Classification Number C07D 401/04
PCT International Application Number PCT/EP2005/008039
PCT International Filing date 2005-07-22
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 10 2004 035 736.6 2004-07-23 Germany